Literature DB >> 15519765

Abnormal migration of human wild-type alpha-synuclein upon gel electrophoresis.

Charbel E-H Moussa1, Christophe Wersinger, Milan Rusnak, York Tomita, Anita Sidhu.   

Abstract

Alpha-synuclein aggregates have been linked to the pathogenesis of Parkinson's disease (PD), with Lewy bodies (LBs) and Lewy neurites (LNs) constituting the pathological hallmarks in the brains of patients with PD and dementia with LBs. LBs are formed by the conversion of soluble monomers of alpha-synuclein into insoluble aggregates. Here we report an abnormal electrophoretic mobility, at a higher molecular weight (MW) than the expected theoretical MW, of both recombinant histidine-tagged human alpha-synuclein, human alpha-synuclein expressed in SH-SY5Y human neuroblastoma cells or Ltk(-) fibroblasts, and rat brain alpha-synuclein, on SDS-PAGE polyacrylamide, but not on Nu-PAGE gradient peptide, gels, suggesting possible alpha-synuclein data misinterpretations associated with gel electrophoresis. These studies raise important considerations about the type of protein gel electrophoresis system suitable to study the alterations of alpha-synuclein associated with neurodegeneration, PD and other synucleinopathies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519765     DOI: 10.1016/j.neulet.2004.09.004

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Dopamine-induced α-synuclein oligomers show self- and cross-propagation properties.

Authors:  Matthew S Planchard; Sarah E Exley; Sarah E Morgan; Vijayaraghavan Rangachari
Journal:  Protein Sci       Date:  2014-08-01       Impact factor: 6.725

2.  Site-saturation mutagenesis of leucine 134 of Bacillus licheniformis nucleotide exchange factor GrpE reveals the importance of this residue to the co-chaperone activity.

Authors:  Min-Guan Lin; Bo-En Chen; Wan-Chi Liang; Wei-Mou Chou; Jiau-Hua Chen; Lih-Ying Kuo; Long-Liu Lin
Journal:  Protein J       Date:  2010-07       Impact factor: 2.371

3.  Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants.

Authors:  Cintia Roodveldt; Adahir Labrador-Garrido; Elena Gonzalez-Rey; Rafael Fernandez-Montesinos; Marta Caro; Christian C Lachaud; Christopher A Waudby; Mario Delgado; Christopher M Dobson; David Pozo
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

4.  A variable-length PCR target protein of Ehrlichia chaffeensis contains major species-specific antibody epitopes in acidic serine-rich tandem repeats.

Authors:  Tian Luo; Xiaofeng Zhang; Abdul Wakeel; Vsevolod L Popov; Jere W McBride
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

5.  Desipramine induced changes in the norepinephrine transporter, alpha- and gamma-synuclein in the hippocampus, amygdala and striatum.

Authors:  Alexis M Jeannotte; John G McCarthy; Anita Sidhu
Journal:  Neurosci Lett       Date:  2009-10-08       Impact factor: 3.046

6.  Acetylcholinesterase associates differently with its anchoring proteins ColQ and PRiMA.

Authors:  Hiba Noureddine; Stéphanie Carvalho; Claudine Schmitt; Jean Massoulié; Suzanne Bon
Journal:  J Biol Chem       Date:  2008-05-29       Impact factor: 5.157

7.  Assessment of α-synuclein secretion in mouse and human brain parenchyma.

Authors:  Evangelia Emmanouilidou; Dimitris Elenis; Themis Papasilekas; Georgios Stranjalis; Kyriaki Gerozissis; Penelopi C Ioannou; Kostas Vekrellis
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

Review 8.  Aptamers Selected for Recognizing Amyloid β-Protein-A Case for Cautious Optimism.

Authors:  Farid Rahimi
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

Review 9.  Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.

Authors:  Fatemeh Nouri Emamzadeh
Journal:  J Mol Neurosci       Date:  2017-07-10       Impact factor: 3.444

10.  A method of purifying alpha-synuclein in E. coli without chromatography.

Authors:  Sumaer Kamboj; Chase Harms; Lokender Kumar; Daniel Creamer; Colista West; Judith Klein-Seetharaman; Susanta K Sarkar
Journal:  Heliyon       Date:  2021-01-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.